<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOph</journal-id><journal-title-group><journal-title>Open Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2165-7408</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojoph.2020.104029</article-id><article-id pub-id-type="publisher-id">OJOph-103794</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Secondary Stress Induced Central Serous Chorioretinopathy in Bamako: Report of Two Cases
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rodrigue</surname><given-names>Romuald Elien Gagnan Yan Zaou Tou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adama</surname><given-names>Guindo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahamat</surname><given-names>Adam Dicko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Kole Sidibe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aly</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Modibo</surname><given-names>Diarra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Inoussa Lamine Abdoulaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nagnan</surname><given-names>Chieck Rahim Diabate</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamadoun</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>21</day><month>10</month><year>2020</year></pub-date><volume>10</volume><issue>04</issue><fpage>268</fpage><lpage>275</lpage><history><date date-type="received"><day>30,</day>	<month>July</month>	<year>2020</year></date><date date-type="rev-recd"><day>26,</day>	<month>October</month>	<year>2020</year>	</date><date date-type="accepted"><day>29,</day>	<month>October</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Idiopathic central serous chorioretinopathy (ICSC) is characterized by the buildup of fluid leading to circumscribed elevation of the retina within the posterior pole. This condition affects young people between the ages of 20 - 50 years. The disease is seen predominantly in men as compared to women. We report the cases of two (02) patients received in consultation at IOTA-Teaching Hospital between July 2019 and February 2020. 
  Case Presentation: We report two cases of Idiopathic stress central serous chorioretinopathy. The first case is a 37-year-old man that we received in consultation for visual acuity decrease from a sudden installation for 1 hour. The clinical and paraclinical arguments permitted us to retain the diagnosis of Idiopathic stress central serous chorioretinopathy. The patient benefited from laser treatment and the clinical evolution was good. The second case is a 42-year-old man, who consulted for a sudden reduction of visual acuity that had been evolving for 3 weeks. The clinical and paraclinical contexts were in favour of the diagnosis of Idiopathic stress central serous chorioretinopathy. The patient was treated with spironolactone. The clinical evolution was favourable. 
  Conclusion: Our study confirms the existence of central serous chorioretinopathy (CSC) in Black African patients. Studies show the connection between CSC and stress.
 
</p></abstract><kwd-group><kwd>Stress</kwd><kwd> Central Serous Chorioretinopathy</kwd><kwd> Fluorescein Angiography</kwd><kwd> Bamako</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Von Graefe, in 1866, was the first to describe a disease of the macula with recurrent serous detachment and to name it recurrent central retinitis [<xref ref-type="bibr" rid="scirp.103794-ref1">1</xref>]. In 1945, Bennet Klein and Maumenee were the first to postulate that the subretinal fluid was derived from choriocapillaris, through the retinal pigment epithelium (RPE) [<xref ref-type="bibr" rid="scirp.103794-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref3">3</xref>]. Gass and et al, in 1966, provided the classic description of the pathogenesis and clinical features of this condition and term of Idiopathic Central Serous Choroidopathy [<xref ref-type="bibr" rid="scirp.103794-ref4">4</xref>]. Later, the name Central Serous Chorioretinopathy is now accepted because the disease involves both the choroid and retina [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>]. The Central Serous Chorioretinopathy is the collection of fluid between the RPE and the neurosensory retina [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>]. There are two forms: acute and chronic [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>]. The Central Serous Chorioretinopathy is characterized by a functional macular and clinical syndrome of serous retinal detachment, most commonly found in the macular region. Its diagnosis is based on angiographic criteria. The literature reported many risk factors of Central Serous Chorioretinopathy such as: local or systemic corticosteroid therapy, Cushing’s disease and pregnancy by increased production of endogenous cortisol; other risk factors independent are Type A personality, antipsychotic medication, and psychological stress [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>].</p><p>In Europe, in 2018, the Central Serous Chorioretinopathy was the 4th most common retinal pathology after age-related macular degeneration, diabetic retinopathy, and occlusion of the retinal vein branch. Its incidence is estimated at 9.9 cases per 100,000 men and 1.7 cases per 100,000 women [<xref ref-type="bibr" rid="scirp.103794-ref8">8</xref>].</p><p>In Africa, the prevalence of Central Serous Chorioretinopathy is unknown and the published data are disparate [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref13">13</xref>]. The first description of secondary stress central serous chorioretinopathy goes to the Togolese authors. The rarity of reports cases of the Secondary Stress Central Serous Chorioretinopathy leads to the realization of this study whose purpose is to contribute to the description of Stress-induced Central Serous Chorioretinopathy.</p></sec><sec id="s2"><title>2. Methodology</title><p>This is the report of two clinical cases received in the IOTA-Teaching Hospital consultation boxes between June 2019 and February 2020. All methods were approved by our institution’s research committee. History, physical examination, and imaging data were obtained from electronic medical records of the patient in question.</p></sec><sec id="s3"><title>3. Patients and Observation</title><sec id="s3_1"><title>3.1. Case 1</title><p>This is a 37-year-old male admitted for Sudden Visual Acuity Decrease for 1 hour ago. The analysis of his pathological antecedents has no found the notion of local or systemic corticosteroid therapy and antipsychotic medications. At presentation, in the right eye, the distant visual acuity was 1/10 Snellen line. On fundus examination, there was a serous neuroretinal detachment of macular localization measuring about 4 papillary diameters (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)). In the left eye, distant visual acuity was 10/10 Snellen line, the anterior sergment and fundus examinations were found to be normal (<xref ref-type="fig" rid="fig1">Figure 1</xref>(b)). In the right eye, Fluorescein angiography showed “leakage points” like “vapor jet” in the form of abnormal hyperfluorescence with increasing crescendo intensity and localized in serous retinal detachment. Subsequently (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(b)), the etiological investigation revealed in our patient a state of extreme anguish related to the survival of his only child admitted to pediatric intensive care with respiratory assistance for 1 week.</p><p>The discomfort resulting from the decrease in visual acuity motivated the therapeutic option by photo coagulation by an argon laser at the extrafoveal leakage point with impacts of 200 microns, for a period of 100 milliseconds and a power of 100 milliwatts. At one week, distant visual acuity was up to 5/10 Snellen line in the right eye. At the 3rd week, there is no serous retinal detachment at the fundus examination of the right eye and angiography control showed no recurrence, no new thrust, no long-term complication, with a distant visual acuity of 10/10 Snellen line in both eyes then referred to the psychologist for psychological support</p></sec><sec id="s3_2"><title>3.2. Case 2</title><p>This is a 42-year-old male business agent of the orange company, very energetic</p><p>and hyperactive, referred from the MOPTI reference health center for the investigation of Sudden Visual Acuity Decrease evolving for 3 weeks without improvement, associated with an important gene, metamorphopsia, and central scotomas. MOPTI IS one of the conflict region of northern Mali, occupied by terrorism “Jihadists”. The analysis of his pathological antecedents has no found the notion of local or systemic corticostero&#239;de therapy and the antipsychotic medications. At presentation, in the right eye, the distant visual acuity was 3/10. On fundus examination, there was a serous neuroretinal detachment of macular localization measuring about 4 papillary diameters (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a)). In the left eye, distant visual acuity was 10/10 Snellen line, the anterior segment and fundus examinations were found to be normal (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)). In the right eye, Fluorescein angiography did not show the &#171;leakage points&#187; (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Contrary, the image of radial Macula OCT confirms the diagnosis by showing the serous detachment of the neuroretina. Subsequently (<xref ref-type="fig" rid="fig5">Figure 5</xref>), the etiological investigation with the participation of the psychologist revealed in our patient the type-A personality associated with a state of extreme anxiety and emotion due to the uncertainty about his professional activities. He was put on spironolactone tablet 50 mg at a rate of 1 tablet per day for 1 month then referred to the psychologist for psychological support. The resorption of the subretinal liquid was slow and progressive to be complete by the 2nd month of treatment.</p></sec></sec><sec id="s4"><title>3. Discussion</title><p>The first case of Idiopathic Central Serous Chorioretinopathy in African peoples was described by Ballo K P et al. in 1996 at Lom&#233; [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>] followed by Fanny et al. in 2008 at Ivory Coast [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>] and Chrabi et al. in 2017 at Morocco [<xref ref-type="bibr" rid="scirp.103794-ref14">14</xref>]. Each of these authors confirmed the relationship between stress and Idiopathic Central Serous Chorioretinopathy through significant statistical tests (notably Fanny et al. and Chrabi et al.). We think, as do other authors [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref11">11</xref>], that race cannot be considered a significant predictor factor of Idiopathic Central Serous Chorioretinopathy.</p><p>Our patients are both males, in accordance with current literature attesting to the high frequency of this disease in the male gent [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref8">8</xref>]. The rarity of this pathology in Black Africa is linked to the difficulties of access to diagnostic examinations equipment, which remain rare in Black Africa, especially in conflict zones.</p><p>The age of our patients was in the 30 - 50 age range, consistent with earlier work in Europe [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref8">8</xref>] and Africa [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.103794-ref14">14</xref>]. For it is undeniable that Idiopathic Central Serous Chorioretinopathy reaches young men more often. However, some authors in America reported the suspicion of Idiopathic Central Serous Chorioretinopathy cases among girls aged 12-year old in 2012 [<xref ref-type="bibr" rid="scirp.103794-ref15">15</xref>].</p><p>The risk factors in favor of idiopathic origin found in our patients were: stress, extreme anxiety, insomnia, Type-A personality. Similar to the observations of European [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref8">8</xref>] and African [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref11">11</xref>] authors especially that of Ivory Coast [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>].</p><p>In general, the main risk factors for CRC in Africa reported in the literature are:</p><p>23 cases of Idiopathic Central Serous Chorioretinopathy post-stress including 2 in Lom&#233; [<xref ref-type="bibr" rid="scirp.103794-ref9">9</xref>], 2 in Burkina Faso [<xref ref-type="bibr" rid="scirp.103794-ref11">11</xref>], 6 in Ivory Coast [<xref ref-type="bibr" rid="scirp.103794-ref10">10</xref>] and 13 in Morocco [<xref ref-type="bibr" rid="scirp.103794-ref14">14</xref>].</p><p>1 case of Central Serous Chorioretinopathy after the renal transplant in 2005 in Tunisia [<xref ref-type="bibr" rid="scirp.103794-ref16">16</xref>].</p><p>1 case of Central Serous Chorioretinopathy during systemic corticosteroid therapy in 2008 in Burkina Faso [<xref ref-type="bibr" rid="scirp.103794-ref11">11</xref>].</p><p>1 case of Central Serous Chorioretinopathy during systemic corticosteroid therapy in 2014 in Tunisia [<xref ref-type="bibr" rid="scirp.103794-ref13">13</xref>].</p><p>1 case of Central Serous Chorioretinopathy in a pregnant woman in 2014 in Morocco [<xref ref-type="bibr" rid="scirp.103794-ref17">17</xref>].</p><p>2 cases of Central Serous Chorioretinpathy after epidural corticosteroid injection in Morocco in 2015 and 2016 [<xref ref-type="bibr" rid="scirp.103794-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref14">14</xref>].</p><p>As for functional signs, the sudden decrease of visual acuity and metamorphosis were present in our patients. Like the corroboree the literature data [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] - [<xref ref-type="bibr" rid="scirp.103794-ref14">14</xref>].</p><p>The detachment of the neuroretina by the accumulation of serous fluid observed at the fundus in our patients is very characteristic to the Central Serous Chorioretinopathy.</p><p>Fluorescein angiography confirms the diagnosis by showing the presence or absence of leakage points [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref8">8</xref>]. Leak points were only seen at Fluorescein angiography in our first case.</p><p>Further exploration of ophthalmological imaging of confirmation diagnosis, no less important, is the OCT. These newer imaging techniques help in the improved morphological analysis and hence better elucidation of the pathophysiology and management of CSC as well as detection of the occult form [<xref ref-type="bibr" rid="scirp.103794-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.103794-ref7">7</xref>].</p><p>On the other hand, Lahousen T. et al. showed in 2015 that stressful life events and certain personality traits such as aggression have been shown to be associated with increased levels of both catecholamines and corticosteroids [<xref ref-type="bibr" rid="scirp.103794-ref18">18</xref>].</p></sec><sec id="s5"><title>4. Conclusion</title><p>There is no longer any doubt that the Central Serous Chorioretinopathy is also found in African black and its etiology is largely dominated by stress and anxiety, especially related to the military-political and economic crises that are shaking the African continent today. Given the relevance of the subject, it would be desirable to carry out a meta-analysis of all aspects of this affection on the African continent, at least in the melanoderm.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Elien Gagnan Yan Zaou Tou, R.R., Guindo, A., Dicko, M.A., Sidibe, M.K., Sylla, A., Diarra, M., Abdoulaye, M.I.L., Diabate, N.C.R. and Diallo, H. (2020) Secondary Stress Induced Central Serous Chorioretinopathy in Bamako: Report of Two Cases. Open Journal of Ophthalmology, 10, 268-275. https://doi.org/10.4236/ojoph.2020.104029</p></sec></body><back><ref-list><title>References</title><ref id="scirp.103794-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Von Graefe</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>1866</year>)<article-title>Ueber zentrale recidivierende Retinitis</article-title><source> Graefe’s Archives for Clinical and Experimental Ophthalmology</source><volume> 12</volume>,<fpage> 211</fpage>-<lpage>215</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.103794-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bennett, G. (1955) Central Serous Retinopathy. British Journal of Ophthalmology, 39, 605-618. https://doi.org/10.1136/bjo.39.10.605</mixed-citation></ref><ref id="scirp.103794-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maumenee</surname><given-names> A.E. </given-names></name>,<etal>et al</etal>. (<year>1965</year>)<article-title>Sympsium on Macular Diseases: Clinical Manifestations</article-title><source> American Academy of Ophthalmology and Otolaryngology</source><volume> 69</volume>,<fpage> 605</fpage>-<lpage>613</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.103794-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Gass, J.D. and Norton, E.W.D. (2003) Serous Detachment of the Retinal Pigment Epithelium. Retina, 23, 990-1015.</mixed-citation></ref><ref id="scirp.103794-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Prakash, G., Chauhan, N., Jain, S. and Satsangi, S.K. (2003) Central Serous Chorioretinopathy: A Review of the Literature. The Asia-Pacific Journal of Ophthalmology, 2, 104-110. https://doi.org/10.1097/APO.0b013e31829069ee</mixed-citation></ref><ref id="scirp.103794-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Haimovici, R., Koh, S., Gagnon, D.R., Lehrfeld, T. and Wellik, S. Central Serous Chorioretinopathy Case-Control Study Group (2004) Risk Factors for Central Serous Chorioretinopathy: A Case-Control Study. Ophthalmology, 111, 244-249. https://doi.org/10.1016/j.ophtha.2003.09.024</mixed-citation></ref><ref id="scirp.103794-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Liu, B., Deng, T., Zhang, J. (2016) Risk Factors for Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis. Retina, 36, 9-19.https://doi.org/10.1097/IAE.0000000000000837</mixed-citation></ref><ref id="scirp.103794-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Wang, M., Munch, I.C., Hasler, P.W., Prünte, C. and Larsen, M. (2008) Central Serous Chorioretinopathy. Acta Ophthalmologica, 86, 126-145.https://doi.org/10.1111/j.1600-0420.2007.00889.x</mixed-citation></ref><ref id="scirp.103794-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Balo, K.P. and Mihluedo, H. (1996) Choriorétinopathie séreuse centrale idiopathique. à propos de deux cas observés au Togo. Médecine Tropicale, 56, 381-383.</mixed-citation></ref><ref id="scirp.103794-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Fanny, A., Gbé, K., Coulibaly, F., Bérété-Coulibaly, R., Boni, S., Ouattara, A. and Kéita, M. (2008) Choriorétinopathie séreuse centrale: étude de 6 cas observés à Abidjan entre 2003 et 2005, r&amp;#244;le évoqué de la crise ivoirienne. Journal Fran&amp;#231ais d’Ophtalmologie, 31, 1018-1024. https://doi.org/10.1016/S0181-5512(08)74749-1</mixed-citation></ref><ref id="scirp.103794-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, J.W., Daboue, A., Boni, S., Ouedraogo, M. and Sanfo, O. (2008) Resultats de la prise en charge des trois premiers cas de chorioretinopathie sereuse central (CRSC) par photocoagulationau Burkina Faso à propos de 3 cas. Revue International des Sciences Médicales, 10, 51-56.</mixed-citation></ref><ref id="scirp.103794-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tliba, A., Boussetta, N., Metoui, L., Gharsallah, I., Ajili, F., Louzir, B. and Othmani, S. (2016) La choriorétinopathie séreuse centrale secondaire à l’infiltration péridurale de cortico&amp;#239des. La Tunisie Medicale, 94, 166.</mixed-citation></ref><ref id="scirp.103794-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Chaker, N., ChebiL, A., Kort, F., Rim, B. and El Matri, L. (2014) Chorioretinite sereuse centrale atypique chez un patient traite par corticotherapie systemique au long cours. La Tunisie Medicale, 92, 590-591.</mixed-citation></ref><ref id="scirp.103794-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chraibi, F., Benatiya Andaloussi, I., Abdellaoui, M. and Tahri, A. (2017) La Choriorétinopathie séreuse centrale et le stress. Journal de la société Marocaine d’Ophtalmologie, 26, 9-11.</mixed-citation></ref><ref id="scirp.103794-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Velazquez-Martin, J.P., Fulda, E., Domville, D., Graus-Wiechus, F. and Krema, H. (2012) Presumed Idiopathic Central Serous Chorioretinopathy in a 12 Year Old Girl. Case Reports in Ophthalmology, 3, 5-10. https://doi.org/10.1159/000335894</mixed-citation></ref><ref id="scirp.103794-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kamoun, R., Zhioua, R., Beltaief, O., Boussen, I. and Meddeb Ouertani, A. (2005) Choriorétinite séreuse centrale chez un patient greffé du rein: à propos d’un cas. Journal Fran&amp;#231ais d’Ophtalmologie, 28, 51-54. https://doi.org/10.1016/S0181-5512(05)81025-3</mixed-citation></ref><ref id="scirp.103794-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hafidi, Z. and Daoudi, R. (2014) Rare Cause of Decrease in Visual Acuity in Pregnancy. Pan African Medical Journal, 17, Article 86. https://doi.org/10.11604/pamj.2014.17.86.3913</mixed-citation></ref><ref id="scirp.103794-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Lahousen, T., Painold, A., Luxenberger, W., Schienle, A., Kapfhammer, H.P. and Ille, R. (2015) Psychological Factors Associated with Acute and Chronic Central Serous Chorioretinopathy. Nordic Journal of Psychiatry, 70, 1-7. https://doi.org/10.3109/08039488.2015.1041156</mixed-citation></ref></ref-list></back></article>